|
SHCBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.821000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.161100E-03 |
| Normal-vs-Stage2 |
1.616560E-03 |
| Normal-vs-Stage3 |
4.824800E-01 |
| Normal-vs-Stage4 |
3.366000E-01 |
| Stage1-vs-Stage2 |
6.164000E-01 |
| Stage1-vs-Stage3 |
4.766400E-02 |
| Stage1-vs-Stage4 |
3.910600E-01 |
| Stage2-vs-Stage3 |
8.279800E-03 |
| Stage2-vs-Stage4 |
8.198100E-02 |
| Stage3-vs-Stage4 |
6.119200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.121400E-03 |
| Normal-vs-AfricanAmerican |
7.492200E-02 |
| Normal-vs-Asian |
7.265600E-01 |
| Caucasian-vs-AfricanAmerican |
5.145600E-01 |
| Caucasian-vs-Asian |
4.775800E-01 |
| AfricanAmerican-vs-Asian |
6.298600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.242590E-04 |
| Normal-vs-Female |
2.269600E-01 |
| Male-vs-Female |
3.273800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.424500E-03 |
| Normal-vs-Extreme_Weight |
3.211500E-04 |
| Normal-vs-Obese |
1.175720E-02 |
| Normal-vs-Extreme_Obese |
8.862200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.982200E-01 |
| Normal_Weight-vs-Obese |
3.654200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.603600E-01 |
| Extreme_Weight-vs-Obese |
2.789500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.924000E-01 |
| Obese-vs-Extreme_Obese |
5.335200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.699800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.017500E-03 |
| Normal-vs-Age(61-80Yrs) |
9.139900E-03 |
| Normal-vs-Age(81-100Yrs) |
5.992700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.569960E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.352760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.593900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.305200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.435700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.054000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.049700E-04 |
| Normal-VS-Type2 PRCC |
2.114100E-02 |
| Normal-VS-KIRP CIMP |
4.995000E-01 |
| Normal-VS-Unclassified PRCC |
4.297800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.696900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.817600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.874000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.484700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.145000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.665610E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.259700E-03 |
| Normal-vs-N1 |
7.620200E-01 |
| Normal-vs-N2 |
6.583800E-01 |
| N0-vs-N1 |
1.121030E-03 |
| N0-vs-N2 |
1.230030E-01 |
| N1-vs-N2 |
5.370400E-01 |
|
|
